Autologous stem-cell transplantation can be performed safely without the use of blood-product support

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Karen K BallenPatricia A Ford

Abstract

Autologous stem-cell transplantation has been shown to be a curative procedure for a variety of leukemias and lymphomas. Most transplants require RBC and platelet support. We report the ability to perform autologous transplantation without blood-product support. In this study, we treated 26 patients with religious objection to blood products with autologous stem-cell support without the use of any blood products. Patients received a combination of granulocyte colony-stimulating factor (G-CSF), erythropoietin, and interleukin-11 or G-CSF alone to mobilize stem cells. Post-transplant patients received intravenous iron, erythropoietin, G-CSF, and epsilon aminocaproic acid. There were two major bleeding complications (8%), with two treatment-related deaths (8%). There were three minor bleeding complications (12%). The median fall in hemoglobin level was 4.7 g/dL; the median hemoglobin level 30 days after transplantation was 9.2 g/dL. The median total number of days with platelet count less than 10 x 10(9)/L was 4 days; the median days to platelet recovery greater than 20 x 10(9)/L was 12 days. Autologous stem-cell transplantation can be performed safely without the use of any blood products.

References

Oct 1, 1991·Transfusion Medicine Reviews·R K Spence
May 8, 1986·The New England Journal of Medicine·B R Smoller, M S Kruskall
Mar 24, 1994·The New England Journal of Medicine·J O Armitage
Oct 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·T J Vander SalmA D Michelson
Mar 1, 1995·Current Opinion in Hematology·D H Henry, J L Spivak
Jul 23, 1998·The New England Journal of Medicine·P M Mannucci
Aug 5, 2000·Bone Marrow Transplantation·K K BallenP S Becker
Jan 5, 2002·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·B R DeyT R Spitzer
Aug 20, 2002·The Oncologist·Kristine A KnutiRichard T Penson
Sep 11, 2002·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Kajsa LarssonP Ljungman
Oct 3, 2002·British Journal of Haematology·Judith C W Marsh, David H Bevan
Apr 30, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Reem GhalibYehuda Z Patt
Dec 26, 2003·The New England Journal of Medicine·Michel AttalUNKNOWN InterGroupe Francophone du Myélome
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael AuerbachJeevindra Rana

❮ Previous
Next ❯

Citations

Aug 4, 2005·Annals of Hematology·Michael Heuser, Arnold Ganser
Feb 5, 2008·Bone Marrow Transplantation·J M Sloan, K Ballen
Sep 29, 2011·Current Opinion in Hematology·Sherrill J Slichter
Sep 1, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Suvro Sankha DattaMammen Chandy
Feb 27, 2008·Transfusion·María C López, David A Lawrence
Sep 13, 2006·Transfusion·David M Rogers, Kendall P Crookston
Jul 22, 2016·Transfusion Medicine Reviews·Jennifer Webb, Allistair Abraham
Aug 23, 2005·Bone Marrow Transplantation·G J Ruiz-ArgüellesC Manzano
Jan 4, 2020·Bone Marrow Transplantation·Alyssa BeckYuliya P Linhares
Nov 7, 2019·British Journal of Haematology·Firas El Chaer, Karen K Ballen
Apr 1, 2019·Cancer Reports·Rachael Chang LeeChris Karapetis
May 26, 2018·Bone Marrow Transplantation·Rafiullah KhanGuido Tricot
Nov 1, 2009·ISBT Science Series·A ThomsonA Shander
Jan 7, 2021·Journal of the National Comprehensive Cancer Network : JNCCN·Daniel A PollyeaMartin S Tallman
Feb 5, 2021·Leukemia & Lymphoma·Peter A RiedellMichael R Bishop
Nov 2, 2019·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Roberto Luiz da SilvaMaria Cristina Martins de Almeida Macedo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.